Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 19, 2014

View Archived Issues

Otsuka Pharmaceutical recaps highlights of second quarter of fiscal 2014

Trevena releases data from phase IIa/b study of TRV-130 in acute postoperative pain

ObsEva initiates phase II trial of oxytocin receptor antagonist in women undergoing embryo transfer

Wilson Therapeutics begins phase II study of WTX-101 in Wilson disease

Validation of the antifibrogenic activity of a peripherally restricted CB1 antagonist

First possible biomarker for liver disease in alpha-1 antitypsin deficiency identified

RALDH 1 explored as a target for treating obesity and diabetes

Trumenba launched in the U.S.

JCAR-015 leukemia T-cell therapy granted FDA orphan drug designation

Hemispherx's Ampligen blocks critical Ebola viral disease viral protein

P-11520031, a novel T-type calcium channel blocker for neuropathic pain

German organization reports development of anti-parasitic vaccines

The Vanderbilt University patents detail novel mAChR M1 PAMs

Ajinomoto patents glycogen synthase activators

Chong Kun Dang Holdings patent divulges novel HDAC6 inhibitors

Roche discloses new CB2 receptor agonists

Preclinical pharmacology, safety and activity profiling of dual JAK3/ITK inhibitor ARN-4079

Consortium readied to advance development of MicroNeurotrophins for ALS

Actavis completes tender offer for Durata Therapeutics

Investigators develop DNA-based vaccine against Leishmaniasis infection

Inderal approved in Japan for the inhibition of onset of hypoxic spell in RVOTO

Long-acting anticholinergic drug to treat bronchial asthma approved in Japan

Arrowhead Research seeks clearance for phase I trial of ARC-AAT for AAT deficiency

Reckitt Benckiser plans to spin off pharmaceuticals business into Indivior

European Commission grants marketing authorization to Harvoni

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...